Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
15.13
Dollar change
-1.23
Percentage change
-7.52
%
IndexRUT P/E- EPS (ttm)-1.30 Insider Own3.76% Shs Outstand91.00M Perf Week-7.01%
Market Cap1.38B Forward P/E122.13 EPS next Y0.12 Insider Trans-3.04% Shs Float87.61M Perf Month-13.89%
Income-116.00M PEG- EPS next Q0.03 Inst Own100.22% Short Float4.22% Perf Quarter-44.25%
Sales823.60M P/S1.67 EPS this Y147.62% Inst Trans-1.60% Short Ratio4.68 Perf Half Y-31.66%
Book/sh8.04 P/B1.88 EPS next Y-3.65% ROA-10.40% Short Interest3.69M Perf Year-15.85%
Cash/sh1.10 P/C13.79 EPS next 5Y70.00% ROE-16.39% 52W Range14.72 - 29.30 Perf YTD-20.95%
Dividend Est.- P/FCF- EPS past 5Y- ROI-13.47% 52W High-48.36% Beta1.87
Dividend TTM- Quick Ratio1.73 Sales past 5Y4.63% Gross Margin63.96% 52W Low2.79% ATR (14)0.92
Dividend Ex-Date- Current Ratio1.90 EPS Y/Y TTM61.33% Oper. Margin-12.53% RSI (14)30.43 Volatility6.42% 5.36%
Employees2700 Debt/Eq0.20 Sales Y/Y TTM12.15% Profit Margin-14.08% Recom2.60 Target Price23.13
Option/ShortYes / Yes LT Debt/Eq0.18 EPS Q/Q67.52% Payout- Rel Volume2.01 Prev Close16.36
Sales Surprise1.21% EPS Surprise220.86% Sales Q/Q11.15% EarningsNov 07 AMC Avg Volume789.15K Price15.13
SMA20-5.19% SMA50-25.23% SMA200-34.55% Trades Volume1,588,532 Change-7.52%
Date Action Analyst Rating Change Price Target Change
Sep-19-24Initiated Morgan Stanley Equal-Weight $32
Aug-28-24Initiated Wells Fargo Overweight $35
Jun-27-24Initiated Scotiabank Sector Outperform $29
Jun-03-24Resumed Jefferies Underperform $20
May-08-24Upgrade Leerink Partners Market Perform → Outperform $25 → $35
Dec-21-23Resumed Piper Sandler Neutral $23
Dec-19-23Initiated Wells Fargo Equal Weight $20
Dec-14-23Initiated Guggenheim Buy $23
Dec-13-23Initiated Wolfe Research Outperform $28
Jul-05-23Resumed JP Morgan Underweight $18
Nov-20-24 04:30PM
Nov-19-24 08:00AM
07:27AM
Nov-13-24 08:00AM
Nov-08-24 02:26AM
06:30PM Loading…
Nov-07-24 06:30PM
06:00PM
05:02PM
04:05PM
Nov-04-24 08:39AM
Nov-02-24 11:15AM
Nov-01-24 06:55PM
Oct-30-24 08:00AM
Oct-28-24 10:01AM
Oct-22-24 02:19PM
09:00AM Loading…
Oct-16-24 09:00AM
Oct-15-24 09:00AM
Oct-09-24 07:49AM
Oct-08-24 04:05PM
Oct-04-24 06:33AM
Oct-03-24 09:00AM
Oct-01-24 04:05PM
Sep-25-24 06:38PM
Sep-18-24 09:50AM
08:00AM
Sep-16-24 06:37PM
Sep-13-24 01:54AM
01:54AM
Sep-10-24 01:17AM
Sep-05-24 11:31AM
08:00AM Loading…
08:00AM
01:33AM
Sep-04-24 06:50PM
Aug-30-24 09:50AM
Aug-23-24 07:01PM
Aug-21-24 08:00AM
Aug-20-24 07:01PM
Aug-09-24 07:07PM
Aug-08-24 08:16AM
Aug-07-24 10:36PM
Aug-06-24 07:00PM
06:30PM
05:28PM
04:05PM
Aug-01-24 04:05PM
Jul-31-24 08:50AM
Jul-30-24 08:00AM
Jul-17-24 08:00AM
Jul-15-24 02:01PM
Jul-11-24 09:00AM
Jul-10-24 07:53AM
Jul-09-24 09:00AM
Jul-08-24 09:00AM
Jul-03-24 07:07PM
Jul-02-24 09:00AM
Jun-24-24 04:05PM
Jun-12-24 11:46AM
Jun-11-24 09:36AM
08:00AM
Jun-06-24 11:31AM
Jun-05-24 02:35AM
Jun-04-24 09:00AM
Jun-03-24 04:05PM
May-30-24 05:55PM
May-23-24 06:44PM
06:00PM
May-16-24 04:05PM
02:52AM
02:52AM
May-13-24 09:45AM
May-10-24 06:00AM
May-09-24 06:55PM
May-08-24 04:28PM
03:59PM
01:54PM
01:24PM
12:15PM
03:47AM
May-07-24 09:56PM
07:00PM
06:02PM
05:50PM
04:47PM
04:05PM
09:00AM
Apr-30-24 04:05PM
Apr-24-24 10:01AM
Apr-17-24 08:00AM
Apr-16-24 09:15AM
Apr-11-24 10:00AM
Apr-09-24 09:10AM
08:00AM
Mar-28-24 11:30AM
Mar-27-24 07:51AM
Mar-21-24 09:40PM
Mar-20-24 04:05PM
Mar-01-24 09:41AM
Feb-28-24 02:45PM
11:24AM
10:24AM
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DIAZ PAUL JPresident and CEOOct 11 '24Sale22.9315,000343,950962,378Oct 11 05:23 PM
DIAZ PAUL JOfficerOct 11 '24Proposed Sale22.9315,000343,950Oct 11 10:35 AM
Ancona MargaretOfficerAug 21 '24Proposed Sale27.8211,538321,019Sep 16 02:30 PM
DIAZ PAUL JPresident and CEOSep 11 '24Sale26.7215,000400,800977,378Sep 12 04:11 PM
Muzzey DaleChief Scientific OfficerSep 11 '24Sale26.172,10054,961108,013Sep 12 04:09 PM
Muzzey DaleOfficerSep 11 '24Proposed Sale26.172,10054,961Sep 11 03:26 PM
DIAZ PAUL JOfficerSep 11 '24Proposed Sale26.7215,000400,800Sep 11 10:05 AM
Dreismann HeinrichDirectorSep 09 '24Sale27.0510,000270,520121,648Sep 09 05:48 PM
Dreismann HeinrichDirectorSep 10 '24Proposed Sale27.0010,000270,000Sep 09 02:52 PM
Reitan Colleen FDirectorSep 03 '24Sale27.9546,0121,285,85142,533Sep 04 07:38 PM
Reitan Colleen FDirectorSep 03 '24Proposed Sale28.1946,0121,297,078Sep 03 10:11 AM
Ancona MargaretSVP, Chief of StaffAug 21 '24Sale27.8211,538320,98779,366Aug 23 04:16 PM
Kumar RashmiDirectorAug 19 '24Sale28.017,500210,07577,392Aug 20 04:38 PM
Kumar RashmiDirectorAug 19 '24Proposed Sale28.017,500210,075Aug 19 02:46 PM
SPIEGELMAN DANIEL KDirectorJun 04 '24Sale22.053,78883,52532,917Jun 04 05:57 PM
SPIEGELMAN DANIEL KDirectorJun 03 '24Sale22.043,78883,48836,705Jun 04 05:57 PM
DIAZ PAUL JPresident and CEOMay 14 '24Sale25.2195,0002,394,7981,141,166May 15 05:49 PM
DIAZ PAUL JPresident and CEOMay 15 '24Sale25.0775,0001,880,4151,066,166May 15 05:49 PM
DIAZ PAUL JPresident and CEOMay 13 '24Sale25.1357,8441,453,5501,236,166May 15 05:49 PM
Newcomer Lee NisleyDirectorMay 13 '24Sale25.306,200156,86066,650May 15 05:48 PM